OASIS-C
01/23/2017
In the early stages of the transition to OASIS-C2, industry experts encourage agency leaders to focus training on a few items that could impact their bottom lines.
12/12/2016
Two-way communication and completion of the prescribed/recommended action must occur by midnight of the next calendar day after the potential clinically significant medication issue was identified to answer “1 — Yes-Issues found during review” in M2001 (Drug regimen review).
12/05/2016
Carefully capture your patients’ height and weight to ensure CMS accurately risk adjusts for pressure ulcers later.
11/07/2016
Report a diagnosis of diabetes or peripheral vascular disease (PVD)/peripheral arterial disease (PAD) in OASIS item M1028 (Active diagnoses) when either diagnosis meets the criteria for assignment in M1021 or M1023 as a primary or comorbid condition, according to the October 2016 CMS OASIS Q&As.
10/31/2016
Covering a pressure ulcer with a skin graft changes it from a pressure ulcer to a surgical wound. This new guidance from CMS could cost your agency.
10/31/2016
CMS no longer has a central point of communication for agencies to submit OASIS questions. Instead OASIS Education Coordinators (OECs) from all 50 states are being assigned responsibility to respond to inquiries.
10/27/2016
Report a diagnosis of diabetes or peripheral vascular disease (PVD)/peripheral arterial disease (PAD) in OASIS item M1028 (Active diagnoses) when either diagnosis meets the criteria for assignment in M1021 or M1023 as a primary or comorbid condition, according to the October 2016 CMS OASIS Q&As.
10/17/2016
Measure a wound from inside edge to inside edge to correctly document wound size and ensure that tunneling or undermining is correctly assessed even though incomplete healing may be present.
10/10/2016
Agencies should note that as of Sept. 15, the OASIS Q&A help desk at CMSOASISquestions@oasisanswers.com is no longer operational, CMS said in a response to a user inquiry.
09/22/2016
In a complete reversal from previous guidance, coders can now assign I11.0 (Hypertensive heart disease with heart failure) for a patient with diagnoses of hypertension and heart failure, regardless of whether the physician has linked the hypertension to the heart failure.

Login

User Name:
Password: